Back to 
B. Metzler seel. Sohn & Co. AG
B. Metzler seel. Sohn & Co. AG
VKTX
Showing 0 of 4 quarters
Position history for B. Metzler seel. Sohn & Co. AG's holdings in Viking Therapeutics, Inc.
No. B. Metzler seel. Sohn exited its VKTX (Viking Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 11,857 shares worth $220,659. B. Metzler seel. Sohn first reported VKTX in Q2 2023 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.